search
Back to results

Premature Infants in Need of Transfusion (PINT)

Primary Purpose

Anemia of Prematurity

Status
Completed
Phase
Phase 3
Locations
International
Study Type
Interventional
Intervention
Red blood cell transfusion
Sponsored by
McMaster University
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Anemia of Prematurity focused on measuring ELBW premature infants, neonatal transfusion, bronchopulmonary dysplasia, periventricular leukomalacia, ventriculomegaly, retinopathy of prematurity

Eligibility Criteria

undefined - 48 Hours (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria: birth weight <1000g postnatal age <48 hours no transfusion beyond first 6 hours of life estimated gestational age of 30 completed weeks or less Exclusion Criteria: infant considered non-viable by attending physician infant has cyanotic congenital heart disease infant's parents known to be opposed to blood transfusion either parent has hemoglobinopathies or congenital anemias infant has hemolytic disease infant has severe acute hemorrhage, severe shock, severe sepsis with coagulopathy or requires peri-operative transfusion prior treatment with or intention to treat with erythropoietin

Sites / Locations

  • Albany Medical Center
  • Brooklyn Hospital Center
  • Royal Women's Hospital
  • Mercy Hospital for Women
  • Royal Alexandra Hospital
  • IWK Health Centre
  • McMaster University
  • Kingston General Hospital
  • Sunnybrook & Women's College Health Science Centre
  • Royal Victoria Hospital

Outcomes

Primary Outcome Measures

Combined mortality or survival to tertiary hospital discharge without severe morbidity (BPD, severe ROP or brain injury)
Combined mortality or survival with neurodevelopmental disability (non-ambulatory cerebral palsy, blindness, deafness, cognitive delay)

Secondary Outcome Measures

growth in weight and head circumference
time to extubation
time on oxygen
length of hospital stay until discharge home
confirmed necrotizing enterocolitis
apnea requiring treatment
culture-proven infections
use of post-natal steroids
mean levels of hemoglobin
number of transfusions
number of donor exposures
serum ferritin levels
milder forms of cerebral palsy
milder neurologic disorder
personal and social functional capabilities
hydrocephalus requiring a shunt
seizure disorder
respiratory disease
iron nutritional status
physical growth including head size

Full Information

First Posted
September 13, 2005
Last Updated
September 22, 2015
Sponsor
McMaster University
Collaborators
Canadian Institutes of Health Research (CIHR)
search

1. Study Identification

Unique Protocol Identification Number
NCT00182390
Brief Title
Premature Infants in Need of Transfusion (PINT)
Official Title
A Randomized Controlled Trial of Two Hemoglobin Thresholds for Transfusion in Newborns <1000g Birth Weight
Study Type
Interventional

2. Study Status

Record Verification Date
September 2015
Overall Recruitment Status
Completed
Study Start Date
February 2001 (undefined)
Primary Completion Date
February 2003 (Actual)
Study Completion Date
November 2005 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
McMaster University
Collaborators
Canadian Institutes of Health Research (CIHR)

4. Oversight

5. Study Description

Brief Summary
Hypothesis: That a high hemoglobin threshold for transfusion in extremely low birth weight (ELBW) infants is associated with a lower rate of survival without severe morbidity (defined as one or more of retinopathy of prematurity, bronchopulmonary dysplasia, or periventricular leukomalacia/ventriculomegaly). Primary Objective: To determine whether either a liberal or more restrictive threshold of hemoglobin level for red cell transfusion in ELBW infants is safer, by randomizing to either a high transfusion hemoglobin threshold or a low transfusion hemoglobin threshold. Follow-up at a corrected age of 18 months represents a conventional age at which to first assess neurodevelopmental outcomes, and to predict long-term outcomes.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Anemia of Prematurity
Keywords
ELBW premature infants, neonatal transfusion, bronchopulmonary dysplasia, periventricular leukomalacia, ventriculomegaly, retinopathy of prematurity

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
424 (false)

8. Arms, Groups, and Interventions

Intervention Type
Procedure
Intervention Name(s)
Red blood cell transfusion
Primary Outcome Measure Information:
Title
Combined mortality or survival to tertiary hospital discharge without severe morbidity (BPD, severe ROP or brain injury)
Time Frame
neonatal phase
Title
Combined mortality or survival with neurodevelopmental disability (non-ambulatory cerebral palsy, blindness, deafness, cognitive delay)
Time Frame
follow-up phase 18 months corrected age
Secondary Outcome Measure Information:
Title
growth in weight and head circumference
Time Frame
neonatal phase
Title
time to extubation
Time Frame
neonatal phase
Title
time on oxygen
Time Frame
neonatal phase
Title
length of hospital stay until discharge home
Time Frame
neonatal phase
Title
confirmed necrotizing enterocolitis
Time Frame
neonatal phase
Title
apnea requiring treatment
Time Frame
neonatal phase
Title
culture-proven infections
Time Frame
neonatal phase
Title
use of post-natal steroids
Time Frame
neonatal phase
Title
mean levels of hemoglobin
Time Frame
neonatal phase
Title
number of transfusions
Time Frame
neonatal phase
Title
number of donor exposures
Time Frame
neonatal phase
Title
serum ferritin levels
Time Frame
neonatal phase
Title
milder forms of cerebral palsy
Time Frame
follow-up phase 18 months corrected age
Title
milder neurologic disorder
Time Frame
follow-up phase 18 months corrected age
Title
personal and social functional capabilities
Time Frame
follow-up phase 18 months corrected age
Title
hydrocephalus requiring a shunt
Time Frame
follow-up phase 18 months corrected age
Title
seizure disorder
Time Frame
follow-up phase 18 months corrected age
Title
respiratory disease
Time Frame
follow-up phase 18 months corrected age
Title
iron nutritional status
Time Frame
follow-up phase 18 months corrected age
Title
physical growth including head size
Time Frame
follow-up phase 18 months corrected age

10. Eligibility

Sex
All
Maximum Age & Unit of Time
48 Hours
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: birth weight <1000g postnatal age <48 hours no transfusion beyond first 6 hours of life estimated gestational age of 30 completed weeks or less Exclusion Criteria: infant considered non-viable by attending physician infant has cyanotic congenital heart disease infant's parents known to be opposed to blood transfusion either parent has hemoglobinopathies or congenital anemias infant has hemolytic disease infant has severe acute hemorrhage, severe shock, severe sepsis with coagulopathy or requires peri-operative transfusion prior treatment with or intention to treat with erythropoietin
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Haresh Kirpalani, MD, MSc
Organizational Affiliation
McMaster University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Robin K Whyte, MD
Organizational Affiliation
Dalhousie University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Robin S Roberts, MTech
Organizational Affiliation
McMaster University
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Elizabeth Asztalos, MD, MSc
Organizational Affiliation
Sunnybrook & Women's College Health Sciences Centre
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Chad Andersen, MD
Organizational Affiliation
Mercy Hospital for Women
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Morris Blajchman, PhD
Organizational Affiliation
McMaster University
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Nancy Heddle, MSc
Organizational Affiliation
McMaster University
Official's Role
Study Director
Facility Information:
Facility Name
Albany Medical Center
City
Albany
State/Province
New York
ZIP/Postal Code
12208
Country
United States
Facility Name
Brooklyn Hospital Center
City
Brooklyn
State/Province
New York
ZIP/Postal Code
11201
Country
United States
Facility Name
Royal Women's Hospital
City
Melbourne
State/Province
Victoria
ZIP/Postal Code
3053
Country
Australia
Facility Name
Mercy Hospital for Women
City
Melbourne
State/Province
Victoria
ZIP/Postal Code
3084
Country
Australia
Facility Name
Royal Alexandra Hospital
City
Edmonton
State/Province
Alberta
ZIP/Postal Code
T5H 3T9
Country
Canada
Facility Name
IWK Health Centre
City
Halifax
State/Province
Nova Scotia
ZIP/Postal Code
B3P 1R8
Country
Canada
Facility Name
McMaster University
City
Hamilton
State/Province
Ontario
ZIP/Postal Code
L8S 4J9
Country
Canada
Facility Name
Kingston General Hospital
City
Kingston
State/Province
Ontario
ZIP/Postal Code
K7L 2V7
Country
Canada
Facility Name
Sunnybrook & Women's College Health Science Centre
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5S 1B2
Country
Canada
Facility Name
Royal Victoria Hospital
City
Montreal
State/Province
Quebec
ZIP/Postal Code
H3A 1A1
Country
Canada

12. IPD Sharing Statement

Citations:
PubMed Identifier
16939737
Citation
Kirpalani H, Whyte RK, Andersen C, Asztalos EV, Heddle N, Blajchman MA, Peliowski A, Rios A, LaCorte M, Connelly R, Barrington K, Roberts RS. The Premature Infants in Need of Transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants. J Pediatr. 2006 Sep;149(3):301-307. doi: 10.1016/j.jpeds.2006.05.011.
Results Reference
result
PubMed Identifier
19117884
Citation
Whyte RK, Kirpalani H, Asztalos EV, Andersen C, Blajchman M, Heddle N, LaCorte M, Robertson CM, Clarke MC, Vincer MJ, Doyle LW, Roberts RS; PINTOS Study Group. Neurodevelopmental outcome of extremely low birth weight infants randomly assigned to restrictive or liberal hemoglobin thresholds for blood transfusion. Pediatrics. 2009 Jan;123(1):207-13. doi: 10.1542/peds.2008-0338.
Results Reference
result

Learn more about this trial

Premature Infants in Need of Transfusion (PINT)

We'll reach out to this number within 24 hrs